MDT

100.01

+0.25%↑

146.96

+0.77%↑

VEEV

244.4

+2.32%↑

HQY

97.41

-0.3%↓

PHR.US

16.95

-3.09%↓

MDT

100.01

+0.25%↑

146.96

+0.77%↑

VEEV

244.4

+2.32%↑

HQY

97.41

-0.3%↓

PHR.US

16.95

-3.09%↓

MDT

100.01

+0.25%↑

146.96

+0.77%↑

VEEV

244.4

+2.32%↑

HQY

97.41

-0.3%↓

PHR.US

16.95

-3.09%↓

MDT

100.01

+0.25%↑

146.96

+0.77%↑

VEEV

244.4

+2.32%↑

HQY

97.41

-0.3%↓

PHR.US

16.95

-3.09%↓

MDT

100.01

+0.25%↑

146.96

+0.77%↑

VEEV

244.4

+2.32%↑

HQY

97.41

-0.3%↓

PHR.US

16.95

-3.09%↓

Inicio・Lista de Acciones・Harmony Biosciences Holdings Inc

Harmony Biosciences Holdings Inc

Abierto

SectorSalud

37.55 0.51

Comprar Vender

Resumen

Variación precio

24h

Actual

Mínimo

37.18

Máximo

37.74

Métricas clave
By Trading Economics
Ingresos	11M 51M
Ventas	39M 239M
P/B Media del Sector	11.593 87.826
BPA	1.08
Margen de beneficio	21.242
Empleados	268
EBITDA	14M 73M

Recomendaciones
By TipRanks
Recomendaciones	Comprar
Estimación a 12 meses	+18.64% upside

Estadísticas de Mercado
By TradingEconomics
Capitalización de Mercado	429M 2.1B
Apertura anterior	37.04
Cierre anterior	37.55

Noticias sobre sentimiento de mercado

By Acuity

34%

66%

106 / 372 Clasificación en Healthcare

Puntuación técnica

By Trading Central

Confianza

Weak Bullish Evidence

29.8 / N/A Soporte y Resistencia

Harmony Biosciences Holdings Inc Gráfico

El rendimiento pasado no es un indicador fiable de resultados futuros.

Noticias Relacionadas

7 ene 2026, 23:11 UTC

Ganancias

Samsung Electronics Expects Record Fourth-Quarter Profit Beat

7 ene 2026, 22:55 UTC

Principales Movimientos del Mercado

Defense Stocks Rebound After Trump Says He Wants $1.5 Trillion Military Budget in 2027

7 ene 2026, 21:39 UTC

Principales Movimientos del Mercado

Raytheon Down Following Trump Post Criticizing Company

7 ene 2026, 20:13 UTC

Principales Movimientos del Mercado

AbbVie, Revolution Medicines Stocks Gain on Report of Possible Acquisition

7 ene 2026, 20:03 UTC

Principales Movimientos del Mercado

Defense Contractor Shares Fall on Trump's Push to Ban Industry Dividends, Buybacks, Limit Executive Pay

7 ene 2026, 23:46 UTC

Charlas de Mercado

Global Forex and Fixed Income Roundup: Market Talk

7 ene 2026, 23:46 UTC

Charlas de Mercado

Nikkei May Decline as China-Japan Tensions Linger -- Market Talk

7 ene 2026, 23:42 UTC

Adquisiciones, fusiones, absorciones

Warner Discovery Rejects Paramount's Amended Hostile Bid -- 5th Update

7 ene 2026, 23:34 UTC

Charlas de Mercado

Gold Edges Higher Amid Lingering Geopolitical Risks -- Market Talk

7 ene 2026, 23:29 UTC

Adquisiciones, fusiones, absorciones

Constellation Closes Deal for Calpine, Creating Biggest Electricity Generator -- Barrons.com

7 ene 2026, 22:48 UTC

Charlas de Mercado

Infratil's Discount to Net Asset Value Too Good to Ignore -- Market Talk

7 ene 2026, 22:46 UTC

Ganancias

Samsung Electronics Estimates 2025 Rev KRW332.770T Vs KRW300.870T >005930.SE

7 ene 2026, 22:45 UTC

Ganancias

Samsung Electronics Estimates 2025 Oper Pft KRW43.530T Vs KRW32.730T >005930.SE

7 ene 2026, 22:43 UTC

Adquisiciones, fusiones, absorciones

Revolution Medicines Draws Takeover Interest -- 2nd Update

7 ene 2026, 22:42 UTC

Ganancias

Samsung Electronics 4Q Oper Pft Estimate Beat FactSet-Compiled Consensus Forecast

7 ene 2026, 22:41 UTC

Ganancias

Samsung Electronics Sees 4Q Oper Pft KRW20.000T Vs KRW6.490T >005930.SE

7 ene 2026, 22:41 UTC

Ganancias

Samsung Electronics Sees 4Q Rev KRW93.000T Vs KRW75.790T >005930.SE

7 ene 2026, 22:40 UTC

Principales Movimientos del Mercado

Defense Stocks Rebound After Trump Says He Wants $1.5T Military Budget in 2027

7 ene 2026, 22:31 UTC

Charlas de Mercado

Macro Tailwinds Strengthen for Chalice Mining -- Market Talk

7 ene 2026, 22:22 UTC

Charlas de Mercado

Northern Star's Run of Disruptions Increasingly a Concern -- Market Talk

7 ene 2026, 22:01 UTC

Charlas de Mercado

Valuations of New Zealand Property Stocks Supportive -- Market Talk

7 ene 2026, 21:50 UTC

Charlas de Mercado

Basic Materials Roundup: Market Talk

7 ene 2026, 21:46 UTC

Charlas de Mercado

Northern Star's Revised Guidance Looks Achievable -- Market Talk

7 ene 2026, 21:22 UTC

Adquisiciones, fusiones, absorciones

Eli Lilly to Buy Ventyx Biosciences for $14 a Share >LLY VTYX

7 ene 2026, 21:18 UTC

Adquisiciones, fusiones, absorciones

Lilly To Acquire Ventyx Biosciences To Advance Oral Therapies Targeting Inflammatory-mediated Diseases >LLY VTYX

7 ene 2026, 21:05 UTC

Adquisiciones, fusiones, absorciones

Warner Discovery Rejects Paramount's Amended Hostile Bid -- 4th Update

7 ene 2026, 20:29 UTC

Adquisiciones, fusiones, absorciones

AbbVie Near Deal for Revolution Medicines -- Update

7 ene 2026, 20:27 UTC

Charlas de Mercado

U.S. Natural Gas Futures Snap Losing Streak -- Market Talk

7 ene 2026, 19:58 UTC

Charlas de Mercado

Oil Falls As U.S. to Receive Sanctioned Venezuelan Crude -- Market Talk

7 ene 2026, 19:48 UTC

Principales Movimientos del Mercado

Defense Contractor Shares Fall on Trump's Push to Ban Industry Dividends, Buybacks, Limit Exec Pay

Comparación entre iguales

Cambio de precio

Harmony Biosciences Holdings Inc Esperado

Precio Objetivo

By TipRanks

18.64% repunte

Estimación a 12 meses

Media 43.6 USD 18.64%

Máximo 55 USD

Mínimo 32 USD

De acuerdo con 6 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Harmony Biosciences Holdings Inc Dist en los últimos 3 meses.

Consenso

By TipRanks

Comprar

6 ratings

Comprar

Mantener

Vender

De acuerdo con 6 analistas que ofrecen calificaciones bursátiles a para Harmony Biosciences Holdings Inc Dist en los últimos 3 meses.

Puntuación técnica

By Trading Central

29.8 / N/ASoporte y Resistencia

Bullish events outweigh bearish events.

Recent bullish events outweigh bearish events.

All events are bearish.

Sentimiento

By Acuity

106 / 372 Clasificación en Salud

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

Acerca de Harmony Biosciences Holdings Inc

Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, focuses on developing and commercializing therapies for patients with rare and other neurological diseases in the United States. The company offers WAKIX (pitolisant), a molecule with a novel mechanism of action for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. It also offers HBS-102, a melanin-concentrating hormone receptor 1 for MCH neurons. The company was formerly known as Harmony Biosciences II, Inc. and changed its name to Harmony Biosciences Holdings, Inc. in February 2020. Harmony Biosciences Holdings, Inc. was incorporated in 2017 and is headquartered in Plymouth Meeting, Pennsylvania.